KALV: KalVista Pharmaceuticals, Inc. Stock

by  •  • Comments Off on KALV: KalVista Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 423.02
Enterprise Value ($M) 287.24
Book Value ($M) 133.99
Book Value / Share 2.71
Price / Book 3.16
NCAV ($M) 125.43
NCAV / Share 2.54
Price / NCAV 3.37

Profitability (mra)
Return on Invested Capital (ROIC) -1.12
Return on Assets (ROA) -1.13
Return on Equity (ROE) -1.37

Liquidity (mrq)
Quick Ratio 6.87
Current Ratio 6.87

Balance Sheet (mrq) ($M)
Current Assets 152.27
Assets 160.83
Liabilities 26.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G Vestal Point Capital, LP 9.30
11-14 13G/A Suvretta Capital Management, Llc 9.99 61.29
11-14 13G/A Tang Capital Management Llc 9.99
11-13 13G Capital World Investors 7.80
11-12 13G/A Adage Capital Management, L.P. 3.29
11-12 13G/A Vanguard Group Inc 4.97 0.00
11-07 13D/A Frazier Life Sciences Public Fund, L.P. 10.00 32.54
04-01 13D/A TCG Crossover GP I, LLC 3.20 -50.17
02-26 13G Adage Capital Partners Gp, L.l.c. 6.87
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 14.00 35.01
02-14 13G/A Tang Capital Partners Lp 9.96 7.63
02-12 13G Saturn V Capital Management LLC 4.10
02-09 13G/A Fmr Llc 0.15 -96.11
01-29 13G BlackRock, Inc. 6.50 42.58

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-12-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-09-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-03-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-23 27,890 162,245 17.19
2025-01-22 44,546 180,968 24.62
2025-01-21 55,763 267,786 20.82

(click for more detail)

Similar Companies
IVVD – Invivyd, Inc. IXHL – Incannex Healthcare Inc.
JANX – Janux Therapeutics, Inc. KLTO – Klotho Neurosciences, Inc.
KOD – Kodiak Sciences Inc.


Financial data and stock pages provided by
Fintel.io